Alpine Bank Wealth Management’s Pfizer PFE Stock Holding History

Alpine Bank Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$773K	Sell	32,082 -8	-0%	-$209	0.1%	107
2026 Q1	$901K	Sell	32,090 -1,209	-4%	-$32.2K	0.13%	88
2025 Q4	$829K	Sell	33,299 -647	-2%	-$16.3K	0.12%	87
2025 Q3	$865K	Sell	33,946 -514	-1%	-$12.7K	0.12%	85
2025 Q2	$835K	Hold	34,460	–	–	0.13%	83
2025 Q1	$873K	Buy	+34,460	New	+$902K	0.14%	76
2024 Q3	$928K	Buy	+32,064	New	+$935K	0.15%	76

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Alpine Bank Wealth Management's PFE Position: Q2 2026 in Review

Alpine Bank Wealth Management reduced its Pfizer (PFE) stake by 0.02% in Q2 2026, selling an estimated $209 and leaving 32,082 shares worth $773K. The position accounts for 0.1% of the portfolio, ranked #107.

Alpine Bank Wealth Management first reported a position in PFE in Q3 2024 and has held it in 7 quarters since. The position peaked at $928K in Q3 2024. 2,836 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Alpine Bank Wealth Management held 32,082 shares of Pfizer worth $773K as of Q2 2026.
Alpine Bank Wealth Management sold 8 Pfizer shares in Q2 2026, an estimated $209.
Pfizer made up 0.1% of Alpine Bank Wealth Management's portfolio in Q2 2026, its #107 holding.
Alpine Bank Wealth Management first reported a position in Pfizer in Q3 2024 and has held it in 7 quarters since.
Alpine Bank Wealth Management's Pfizer position peaked at $928K in Q3 2024.
2,836 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Alpine Bank Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.